Lipocine Files 8-K
Lipocine Inc. files 8-K with SEC, disclosing other events and financial statements. No details given.
Filed: 2026-05-26 AccNo: 0001493152-26-025270 Size: 20 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Lipocine Inc. files 8-K with SEC, disclosing other events and financial statements. No details given.
Filed: 2026-05-26 AccNo: 0001493152-26-025270 Size: 20 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits